CROI 2026

At CROI 2026, Dr Esteban Martinez from Barcelona’s Hospital Clinic spoke with aidsmap.com's Roger Pebody about the impact of statins on high blood pressure in people living with HIV.

At CROI 2026, Professor Chloe Orkin from Queen Mary University of London spoke to aidsmap.com's Roger Pebody about a combination of bictegravir and lenacapavir which could be an option for people taking complex regimens.

At CROI 2026, Professor John Frater from the University of Oxford spoke with aidsmap.com's Roger Pebody about how broadly neutralising antibodies work in the body and help the immune system.

At the Conference on Retroviruses and Opportunistic Infections (CROI 2026), Dr Andrew Hill from the University of Liverpool spoke to aidsmap.com's Roger Pebody about PrEP uptake being too low globally to make a difference to the HIV epidemic.

At the Conference on Retroviruses and Opportunistic Infections (CROI 2026), Professor Kate Seib and Professor Andrew Grulich talked to aidsmap.com's Roger Pebody about the 4CMenB vaccine against gonorrhoea.

At the Conference on Retroviruses and Opportunistic Infections (CROI 2026), Dr Sari Reisner from the University of Michigan spoke to aidsmap.com's Roger Pebody about HIV incidence in trans women in the United States.

At the Conference on Retroviruses and Opportunistic Infections (CROI 2026), Professor Jürgen Rockstroh from the University of Bonn spoke to aidsmap.com's Roger Pebody about two-drug HIV treatment doravirine and islatravir.